Clinical Trial Update: Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and effectiveness of the Avonex single-use autoinjector in people with multiple sclerosis; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2011-08-09